Skip to main content
. 2018 Mar 6;6:19. doi: 10.1186/s40425-018-0330-1

Table 4.

Summary by frequency of AEs of any severity, felt to possibly, likely, or almost certainly caused by injection of vaccines

Adverse Event All (N = 42) TCV (n = 24) DCV (n = 18) P value
Injection site reactions 28 (67%) 16 (67%) 12 (67%) 1.00
Flu-like symptoms 14 (33%) 9 (38%) 5 (28%) 0.742
Nausea 8 (19%) 5 (21%) 3 (17%) 1.00
Bone discomfort 7 (17%) 4 (17%) 3 (17%) 1.00
Headache 6 (14%) 3 (12%) 3 (17%) 1.00
Fatigue 5 (12%) 5 (21%) 0 (0%) 0.060
Chills 5 (12%) 1 (4%) 4 (22%) 0.146
Pruritus 3 (7% 2 (8%) 1 (6%) 1.00
Arthralgias 3 (7%) 1 (4%) 2 (11%) 0.567
Fever 3 (7%) 3 (12%) 0 (0%) 0.247
Rash 2 (5%) 2 (8%) 0 (0%) 0.498
Hives (urticarial) 2 (5%) 2 (8%) 0 (0%) 0.498
Shingles 2 (5%) 2 (8%) 0 (0%) 0.498
Myalgias 1 (2%) 0 (0%) 1 (6%) 0.429

TCV tumor cell vaccine, DCV dendritic cell vaccine